Protonix “Best Price” Reporting Subject Of Boston Prosecutor’s Subpoena
This article was originally published in The Pink Sheet Daily
Executive Summary
U.S. Attorney’s Office seeks documents dating back to January 2000 on Wyeth’s quarterly calculations of average manufacturer price and “best price” for tablet and intravenous formulations of the proton pump inhibitor, the company says in its 10-K filing.